I think one would be drawing a long bow to think that this application has relevance to the nasal spray.
It is simply a wording change to reflect the use of SPL 7013 as a preventative as well as a treatment. The recommended preventative regine is every other day for 14 days and the current TGA approved wording conflicts with this.
Somewhere else there is an application for the nasal spray and its effects on target viruses. New applications are not published as I understand TGA practice.
Ann: US patent issued for DEP cabazitaxel nanoparticle, page-39
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
